Burcon NutraScience Corp
TSX:BU
Intrinsic Value
Burcon NutraScience Corp. develops plant proteins and ingredients for use in the food and beverage industries in Canada. [ Read More ]
The intrinsic value of one
BU
stock under the Base Case scenario is
0.006
CAD.
Compared to the current market price of 0.215 CAD,
Burcon NutraScience Corp
is
Overvalued by 97%.
BU's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
BU or that its price is influenced by factors unrelated to fundamentals.
Burcon NutraScience Corp's market capitalization is 26.2m CAD.
BU stock price is 0.215 CAD.
BU stock (0.006 CAD) is 97% less than its price (0.215 CAD).
BU. Open DCF Valuation
BU stock (0.006 CAD) is 97% less than its price (0.215 CAD). Open Relative Valuation
BU has upside potential of 760% compared to the average analyst price target.
Open Wall St Estimates
BU's long-term assets (9m CAD) exceed its long-term liabilties (6m CAD).
BU's short-term assets (1m CAD) exceed its short-term liabilties (667k CAD).
BU's Revenue has dropped by 59% over the past 12 months.
BU's ROE (Return on Equity) has significantly decreased in the last 3 years from -2% to -170%, and is approaching profitability.
BU's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -24% to -89%, and is approaching profitability.
BU's D/E (Debt to Equity) is equal to 1.9.
BU has negative Operating Income for the last twelve months.
BU has negative Net Income for the last twelve months.
BU's ROE (Return on Equity) for the past 12 months is negative and is equal to -170%.
BU's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -89%.
BU has negative Free Cash Flow for the last twelve months.
BU's Revenue has been growing by an exceptional 162% per year for the last 3 years.
BU has positive Net Debt. This means that the company has more debt (5m CAD) than cash and short-term investments (675k CAD).
BU has negative three-year average ROE (Return on Equity): -75%. The company is not efficient at transforming stockholders' equity into net income.
BU has negative three-year average ROIC (Return on Invested Capital): -48%. The company is not efficient at using invested capital to generate operating income.
BU's Altman Z-Score is very low and is equal to -21.15.
BU doesn't generate enough operating income (-7m CAD) to safely cover interest payments on its debt (140k CAD).
Valuation Backtest
Burcon NutraScience Corp
Run backtest to discover the historical profit from buying and selling
BU
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Burcon NutraScience Corp
Balance Sheet Decomposition
Burcon NutraScience Corp
| Current Assets | 1.1m |
| Cash & Short-Term Investments | 675.4k |
| Receivables | 130.7k |
| Other Current Assets | 281.2k |
| Non-Current Assets | 7.7m |
| PP&E | 918.5k |
| Intangibles | 1.3m |
| Other Non-Current Assets | 5.5m |
| Current Liabilities | 666.5k |
| Accounts Payable | 629.6k |
| Other Current Liabilities | 36.9k |
| Non-Current Liabilities | 5.3m |
| Long-Term Debt | 5.3m |
Earnings Waterfall
Burcon NutraScience Corp
|
Revenue
|
180k
CAD
|
|
Operating Expenses
|
-7.1m
CAD
|
|
Operating Income
|
-6.9m
CAD
|
|
Other Expenses
|
-253.6k
CAD
|
|
Net Income
|
-7.2m
CAD
|
Free Cash Flow Analysis
Burcon NutraScience Corp
What is Free Cash Flow?
BU Profitability Score
Profitability Due Diligence
Burcon NutraScience Corp's profitability score is 18/100. The higher the profitability score, the more profitable the company is.
Score
Burcon NutraScience Corp's profitability score is 18/100. The higher the profitability score, the more profitable the company is.
BU Solvency Score
Solvency Due Diligence
Burcon NutraScience Corp's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Score
Burcon NutraScience Corp's solvency score is 24/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BU Price Targets Summary
Burcon NutraScience Corp
According to Wall Street analysts, the average 1-year price target for
BU
is 1.85 CAD
.
Shareholder Return
BU Price
Burcon NutraScience Corp
| Average Annual Return | 87.1% |
| Standard Deviation of Annual Returns | 176.88% |
| Max Drawdown | -98% |
| Market Capitalization | 26.2m CAD |
| Shares Outstanding | 121 732 000 |
| Percentage of Shares Shorted | 0.1% |
Company Profile
Burcon NutraScience Corp
Country
Industry
Market Cap
Dividend Yield
Description
Burcon NutraScience Corp. develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company is headquartered in Vancouver, British Columbia. The firm is engaged in development of plant protein extraction and purification technology in the field of functional, renewable plant proteins. The firm has a portfolio of composition, application and process patents covering plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds. The firm has developed pea proteins that it has branded Peazazz and Peazac, and over three canola protein products, Puratein, Supertein and Nutratein. The firm also includes CLARISOY, which is a soy protein. The Company’s subsidiaries include Burcon NutraScience (MB) Corp. and Burcon NutraScience Holdings Corp.
Contact
IPO
Employees
Officers
The intrinsic value of one
BU
stock under the Base Case scenario is
0.006
CAD.
Compared to the current market price of 0.215 CAD,
Burcon NutraScience Corp
is
Overvalued by 97%.
You don't have any saved screeners yet
